Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other 3Breast 1

Conditions

Obesity 6Weight Loss 3Polycystic Ovary Syndrome 3Overweight 3Obesity, Abdominal 1Metabolic Diseases 1Intermittent Fasting 1Infertility 1Glucocorticoid Receptor Deficiency 1Fasting 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Exercise 6Nutrition Assessment 4Counseling 4Methods 3Caloric Restriction 3Tirzepatide 2Resistance Training 2Naltrexone 2Metformin 2Megestrol Acetate 2Exenatide 2Educational Status 2Early Intervention, Educational 2Diet 2Cognitive Behavioral Therapy 2Bupropion 2Blood Specimen Collection 2semaglutide 1licogliflozin 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Trehalase 1Tablets 1Standard of Care 1Psychology, Positive 1Propofol 1Progestins 1Patient Navigation 1Motivational Interviewing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Overweight × Caloric Restriction × Other × Clear all
NCT05629858 2025-03-13

Time Restricted Eating for the Treatment of PCOS

University of Illinois at Chicago

Phase NA Completed
76 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Overweight

NCT01716429 2019-04-18

HER Health

University of South Carolina

Phase NA Withdrawn
Other

Infertility, Obesity, Polycystic Ovary Syndrome, Weight Loss, Overweight

NCT02940470 2018-08-03

Weight Loss Pilot Study in Postmenopausal Breast Cancer Survivors

USDA Grand Forks Human Nutrition Research Center

Phase NA Completed
22 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡